3-6-16 & 17, Street No. 19, Opp.

Lane to Tanishq, Chandra Nagar, Himayatnagar, Hyderabad - 500029

TEST REPORT

Name : Mr. S A QADER Registered on : 07-Oct-2024 17:14

Age/Gender : 72 Years / Male BirthDate : 02-Aug-1952 Collected on : 07-Oct-2024 17:20
Registration ID : 240510036945 Released on : 07-Oct-2024 21:41
Ref. By : Dr. MOHAMMED ATEEQ UR RAHMAN Printed on : 08-Oct-2024 09:53
Sample Type : Whole Blood - EDTA Regn Centre : Vijayanagar - 51

GLYCATED HAEMOGLOBIN (HbA1C)

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

Glycated Haemoglobin : 9.4 % Non Diabetic : < 5.7
Pre - Diabetic Range : 5.7 - 6.4
Diabetic Range : >/= 6.5
Method: High performance liquid chromatography
Remarks: Elevated LA1c
Interpretation / Comments:
---------------------------------
• Glycated hemoglobin is proportional to mean plasma glucose level during previous 6-12 weeks.
• Values may not be comparable with different methodologies and even different laboratories using same methodology.
• Perform A1c at least twice annually in diabetes patients to ascertain meeting of goals.
• Perform A1c test quarterly in diabetes patients whose therapy has changed and who are not meeting goals.
• Recommended goal of A1c is < 7%.
• ADA guidelines 2023.
• Presence of abnormal Hb may affect HbA1C result.

Page 1 of 10
 3-6-16 & 17, Street No. 19, Opp. Lane to Tanishq, Chandra Nagar, Himayatnagar, Hyderabad - 500029

TEST REPORT

Name : Mr. S A QADER Registered on : 07-Oct-2024 17:14

Age/Gender : 72 Years / Male BirthDate : 02-Aug-1952 Collected on : 07-Oct-2024 17:20
Registration ID : 240510036945 Released on : 07-Oct-2024 21:41
Ref. By : Dr. MOHAMMED ATEEQ UR RAHMAN Printed on : 08-Oct-2024 09:53
Sample Type : Whole Blood - EDTA Regn Centre : Vijayanagar - 51

GLYCATED HAEMOGLOBIN (HbA1C)

DR. MANUGNA A
MD BIOCHEMISTRY
MC-2657 Registration No: TSMC/FMR/31118

Page 2 of 10
 3-6-16 & 17, Street No. 19, Opp. Lane to Tanishq, Chandra Nagar, Himayatnagar, Hyderabad - 500029

TEST REPORT

Name : Mr. S A QADER Registered on : 07-Oct-2024 17:14

Age/Gender : 72 Years / Male BirthDate : 02-Aug-1952 Collected on : 07-Oct-2024 17:20
Registration ID : 240510036945 Released on : 07-Oct-2024 21:41
Ref. By : Dr. MOHAMMED ATEEQ UR RAHMAN Printed on : 08-Oct-2024 09:53
Sample Type : Fluoride Plasma Regn Centre : Vijayanagar - 51

PLASMA GLUCOSE (RANDOM)

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

Plasma Glucose (Random) : 361 mg/dL Normal :70-140
Method: Hexokinase Impaired Glucose tolerance :141-
199
Diabetes :>/= 200

Interpretation / Comments :
--------------------------------
• ADA Guidelines (2023) are adopted for the evaluation of diabetic status.

DR. MANUGNA A
MD BIOCHEMISTRY
MC-2657 Registration No: TSMC/FMR/31118

Page 3 of 10
 3-6-16 & 17, Street No. 19, Opp. Lane to Tanishq, Chandra Nagar, Himayatnagar, Hyderabad - 500029

TEST REPORT

Name : Mr. S A QADER Registered on : 07-Oct-2024 17:14

Age/Gender : 72 Years / Male BirthDate : 02-Aug-1952 Collected on : 07-Oct-2024 17:20
Registration ID : 240510036945 Released on : 08-Oct-2024 09:27
Ref. By : Dr. MOHAMMED ATEEQ UR RAHMAN Printed on : 08-Oct-2024 09:53
Sample Type : Whole Blood - EDTA Regn Centre : Vijayanagar - 51

COMPLETE BLOOD PICTURE (CBP)

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

Haemoglobin : 12.8 gm/dL 13.0 - 17.0
Method: Photometric Measurement
Total RBC Count : 4.4 Cells/cumm 4.5 - 5.5
Method: Coulter Principle
Packed Cell Volume / Hematocrit : 37.4 % 40.0 - 50.0
Method: Calculated
MCV : 84.2 fL 83.0 - 101.0
Method: Derived From RBC Histogram
MCH : 28.7 pg 27.0 - 32.0
Method: Calculated
MCHC : 34.1 gm/dL 31.5 - 34.5
Method: Calculated
RDW : 14.4 % 11.6 - 14.0
Method: Derived From RBC Histogram
Total Leucocytes (WBC) Count : 9100 Cells/cumm 4000 - 10000
Method: Coulter Principle
Differential count
Neutrophils : 59 % 40 - 80
Method: VCS 360 Technology and Microscopy
Lymphocytes : 26 % 20 - 40
Method: VCS 360 Technology and Microscopy
Eosinophils :5 % 1-6
Method: VCS 360 Technology and Microscopy
Monocytes :9 % 2 - 10
Method: VCS 360 Technology and Microscopy
Basophils :1 % 0-2
Method: VCS 360 Technology and Microscopy
Absolute Leucocyte Count
Absolute Neutrophil Count : 5369 Cells/cumm 2000 - 7000
Method: Calculated
Absolute Lymphocyte Count : 2366 Cells/cumm 1000 - 3000
Method: Calculated
Absolute Eosinophil Count : 455 Cells/cumm 20 - 500
Method: Calculated
Absolute Monocyte Count : 819 Cells/cumm 200 - 1000
Method: Calculated

Page 4 of 10
 3-6-16 & 17, Street No. 19, Opp. Lane to Tanishq, Chandra Nagar, Himayatnagar, Hyderabad - 500029

TEST REPORT

Name : Mr. S A QADER Registered on : 07-Oct-2024 17:14

Age/Gender : 72 Years / Male BirthDate : 02-Aug-1952 Collected on : 07-Oct-2024 17:20
Registration ID : 240510036945 Released on : 08-Oct-2024 09:27
Ref. By : Dr. MOHAMMED ATEEQ UR RAHMAN Printed on : 08-Oct-2024 09:53
Sample Type : Whole Blood - EDTA Regn Centre : Vijayanagar - 51

COMPLETE BLOOD PICTURE (CBP)

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

Platelet Count : 268000 Cells/cumm 150000 - 410000
Method: Coulter Principle and Microscopy
Peripheral Smear
RBC : Normocytic Normochromic
Method: Microscopy of Leishman stained smear
WBC : Normal in morphology, maturity and distribution
Method: Microscopy of Leishman stained smear
Platelets : Adequate
Method: Microscopy of Leishman stained smear

DR. SALEHA BEGUM

MC-2657
MD PATHOLOGY
Registration No: APMC/FMR/87815

Page 5 of 10
 3-6-16 & 17, Street No. 19, Opp. Lane to Tanishq, Chandra Nagar, Himayatnagar, Hyderabad - 500029

TEST REPORT

Name : Mr. S A QADER Registered on : 07-Oct-2024 17:14

Age/Gender : 72 Years / Male BirthDate : 02-Aug-1952 Collected on : 07-Oct-2024 17:20
Registration ID : 240510036945 Released on : 08-Oct-2024 09:37
Ref. By : Dr. MOHAMMED ATEEQ UR RAHMAN Printed on : 08-Oct-2024 09:53
Sample Type : Serum Regn Centre : Vijayanagar - 51

URIC ACID

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

Uric Acid : 5.1 mg/dL 3.5 - 7.2
Method: Uricase-Peroxidase

Interpretation / Comments :
----------------------------------
• Useful for monitoring therapeutic management of gout and chemotherapeutic treatment of neoplasms.

DR. MANUGNA A
MD BIOCHEMISTRY
MC-2657 Registration No: TSMC/FMR/31118

Page 6 of 10
 3-6-16 & 17, Street No. 19, Opp. Lane to Tanishq, Chandra Nagar, Himayatnagar, Hyderabad - 500029

TEST REPORT

Name : Mr. S A QADER Registered on : 07-Oct-2024 17:14

Age/Gender : 72 Years / Male BirthDate : 02-Aug-1952 Collected on : 07-Oct-2024 17:20
Registration ID : 240510036945 Released on : 08-Oct-2024 09:37
Ref. By : Dr. MOHAMMED ATEEQ UR RAHMAN Printed on : 08-Oct-2024 09:53
Sample Type : Serum Regn Centre : Vijayanagar - 51

UREA

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

Urea : 27 mg/dL 17 - 43
Method: Urease/GLDH

Interpretation / Comments :
---------------------------------
• In conjunction with serum creatinine,urea level aids in differential diagnosis of pre-renal,renal and
post-renal hyperuremia.

DR. MANUGNA A
MD BIOCHEMISTRY
MC-2657 Registration No: TSMC/FMR/31118

Page 7 of 10
 3-6-16 & 17, Street No. 19, Opp. Lane to Tanishq, Chandra Nagar, Himayatnagar, Hyderabad - 500029

TEST REPORT

Name : Mr. S A QADER Registered on : 07-Oct-2024 17:14

Age/Gender : 72 Years / Male BirthDate : 02-Aug-1952 Collected on : 07-Oct-2024 17:20
Registration ID : 240510036945 Released on : 08-Oct-2024 09:37
Ref. By : Dr. MOHAMMED ATEEQ UR RAHMAN Printed on : 08-Oct-2024 09:53
Sample Type : Serum Regn Centre : Vijayanagar - 51

CREATININE

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

Creatinine : 1.4 mg/dL 0.7 - 1.2
Method: Jaffe Kinetic IDMS traceable

e-GFR (Glomerular Filtration Rate) : 52.8 ml/min/1.73 m² Normal kidney function : >/= 90
Method: Calculation, CKD EPI equation (Please refer to Interpretations for
reference ranges of e-GFR in
different stages of CKD and also
average e-GFR based on age. )
Interpretation / Comments:
Stages of chronic kidney disease (CKD)
Stages Description e-GFR
1 Possible kidney damage (eg: Proteinuria) with normal kidney function >/= 90
2 Mild loss of kidney function 60 - 89
3a Mild to moderate loss of kidney function 45 - 59
3b Moderate to severe loss of kidney function 30 - 44
4 Severe loss of kidney function 15 - 29
5 Kidney failure < 15

Chart for average e-GFR based on age

Age (Yrs) Average e-GFR
20 - 29 116
30 - 39 107
40 - 49 99
50 - 59 93
60 - 69 85
>/= 70 75

Page 8 of 10
 3-6-16 & 17, Street No. 19, Opp. Lane to Tanishq, Chandra Nagar, Himayatnagar, Hyderabad - 500029

TEST REPORT

Name : Mr. S A QADER Registered on : 07-Oct-2024 17:14

Age/Gender : 72 Years / Male BirthDate : 02-Aug-1952 Collected on : 07-Oct-2024 17:20
Registration ID : 240510036945 Released on : 08-Oct-2024 09:37
Ref. By : Dr. MOHAMMED ATEEQ UR RAHMAN Printed on : 08-Oct-2024 09:53
Sample Type : Serum Regn Centre : Vijayanagar - 51

CREATININE

• Serum Creatinine is useful in the diagnosis of renal insufficiency and is more specific and sensitive indicator of renal
disease than serum Urea /BUN.
• Use of simultaneous Urea / BUN and creatinine levels provide more information in the diagnosis of renal
insufficiency.
• GFR is generally considered the best index of overall kidney function.
• Chronic kidney disease is defined as the presence of persistent and usually progressive reduction in GFR.
• Repeated determination of GFR in conjunction with creatinine assay establish whether the patient has stable or
progressive disease.
• GFR is useful for people with chronic kidney disease (CKD) and those with risk factors for CKD (diabetes,
hypertension, cardiovascular disease and family history of kidney disease) to assess the kidney function.
• The CKD-EPI equation is the most widely used IDMS traceable equations for estimating GFR in patients above 18
years of age. This equation includes variables for age and gender, and it may be observed that Kidney may be involved
despite a serum creatinine concentration appearing to be within or just above the Biological Reference Interval. The
results of e-GFR by CKD-EPI equation are normalized to 1.73 m² body surface area. CKD-EPI equation is not valid
for individuals under 18 years of age.
• Limitations of CKD-EPI equation includes imprecise estimates in some individuals especially those suffering from
physiologic limitations of creatinine as filtration markers, thus showing large difference between measured GFR and
e-GFR (estimated GFR).
• Estimates for GFR based on serum creatinine will be less accurate for patients at the extremes of muscle mass (such as
frail elderly, critically ill, cancer patients) and also those with unusual diets, sudden acute renal failure, patients on
dialysis and patients with severe liver disease.
• Confirmatory tests with exogenous measured GFR or directly measured creatinine clearance should be performed for
such individuals.
• The influence of creatinine measurement imprecision at low creatinine conecentrations (and hence high e-GFR) has a
possible contribution to the variability at higher e-GFR values.

DR. MANUGNA A
MC-2657
MD BIOCHEMISTRY
Registration No: TSMC/FMR/31118

Page 9 of 10
 3-6-16 & 17, Street No. 19, Opp. Lane to Tanishq, Chandra Nagar, Himayatnagar, Hyderabad - 500029

TEST REPORT

Name : Mr. S A QADER Registered on : 07-Oct-2024 17:14

Age/Gender : 72 Years / Male BirthDate : 02-Aug-1952 Collected on : 07-Oct-2024 17:20
Registration ID : 240510036945 Released on : 08-Oct-2024 09:37
Ref. By : Dr. MOHAMMED ATEEQ UR RAHMAN Printed on : 08-Oct-2024 09:53
Sample Type : Serum Regn Centre : Vijayanagar - 51

ELECTROLYTES

TEST NAME RESULT UNIT BIOLOGICAL REFERENCE INTERVAL

Sodium : 138 mmol/L 136 - 146
Method: Indirect ISE
Potassium : 4.7 mmol/L 3.5 - 5.1
Method: Indirect ISE
Chlorides : 104 mmol/L 101 - 109
Method: Indirect ISE

Interpretation / Comments :
------------------------------------
• Sodium : Levels of sodium when evaluated with electrolytes aid in assessing acid base balance, water balance and
water intoxication.
• Potassium : Useful in evaluation of electrolyte balance, cardiac arrhythmia, muscular weakness, hepatic
encephalopathy and renal failure.
• Chloride : Useful when assayed along with sodium, potassium and bicarbonate in assessment of electrolyte, acid base
and water balance.

DR. MANUGNA A
MC-2657
MD BIOCHEMISTRY
Registration No: TSMC/FMR/31118
------------------ End of Report ------------------

Page 10 of 10